Femasys Inc. (FEMY)
Makes medical devices that help diagnose and treat women's fertility and reproductive health issues.
$2.99-0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-81.8%
The outlook
Femasys trades near its 52-week low and well below both its 50- and 200-day moving averages, reflecting a downtrend. Analyst coverage shows an average price target roughly 20x the current price, though this extreme disconnect suggests thin or speculative research. Overall sentiment leans bearish at present.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +2019% vs current price
Analyst price target
~12-month$63.33average target+2019.0% vs now
Now $2.99
Low $30.00High $130.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$9.0M
52-wk high
$22.20
52-wk low
$2.73
50-day avg
$5.04
200-day avg
$10.42
Trailing P/E
—